Yunnan Baiyao Group Co.,Ltd (SHE:000538)

Market Cap	102.51B
Revenue (ttm)	40.03B
Net Income (ttm)	4.75B
Shares Out	1.78B
EPS (ttm)	2.66
PE Ratio	21.60
Forward PE	19.43
Dividend	1.19 (2.07%)
Ex-Dividend Date	Nov 25, 2024

Volume	3,651,429
Average Volume	10,269,145
Open	57.02
Previous Close	57.33
Day's Range	57.02 - 57.56
52-Week Range	49.00 - 67.10
Beta	0.57
RSI	57.82
Earnings Date	Apr 1, 2025

About SHE:000538

Yunnan Baiyao Group Co.,Ltd engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally. It provides health products; drugs; medical devices; traditional Chinese medicine resources; and tea products. The company also supplies and distributes medicines. Yunnan Baiyao Group Co., Ltd. was founded in 1902 and is based in Kunming, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1902
• Employees: 9,277
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000538

Financial Performance

In 2024, SHE:000538's revenue was 40.03 billion, an increase of 2.36% compared to the previous year's 39.11 billion. Earnings were 4.75 billion, an increase of 16.02%.